TOP

Press/Media

Gen Re Announces Annual U.S. Critical Illness and Accident Insurance Market Survey Results

Issue: October 2023 | Life/Health North America

The Critical Illness market remains strong, with 2022 new sales and in‑force premium showing increases over 2021 results.

Portland, Maine, October 18, 2023 – Gen Re has released results of its latest U.S. Critical Illness and Accident Insurance Market Survey. This annual survey covers Traditional Individual, Group/Worksite Critical Illness (CI), and Accident products. The majority of new CI sales premium (88%) was attributed to Issue Age and Attained Age group/worksite products.

Thirty-one carriers participated in this year’s survey, reporting $1.8 billion in CI in‑force premium and $684 million in new sales for 2022.

Twenty-eight carriers provided results for their Accident insurance product, reporting $500 million in new sales and $1.7 billion in‑force premium for 2022.

Key results from this year’s survey include:

  • In‑force premium for all CI products combined increased 15% over 2021, based on companies providing data for both years.
  • Group/Worksite Attained Age business accounted for 72% of the total policies/certificates sold in 2022.
  • 74% of respondents met or exceeded their CI sales goals for 2022.
  • For those carriers who provided Accident product data for both years, in‑force premium and policies grew 7% and 11% respectively.

This an annual benchmark survey produced by Gen Re, with the full results available only to participating companies. A summary report is available here.

Gen Re, a Berkshire Hathaway Company, is one of the leading Life & Health and Property & Casualty reinsurers in the world. Our North American Life & Health reinsurance company, General Re Life Corporation, has superior financial strength ratings among Life and Health reinsurers. Gen Re delivers customized reinsurance programs and risk management solutions for the Life, Medicare Supplement, Critical Illness and Individual Disability Income markets. Through our research, we also offer valuable information and insights.

Contact